Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
14 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-01-25 | 2024-03-21 | 217226 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-01-25 | 2024-03-14 | 217229 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-01-25 | 2024-06-20 | 217231 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-09-12 | 2025-12-02 | 237473 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-11-08 | 2025-12-12 | 242358 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2025-05-02 | 2025-08-15 | 256456 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2025-08-29 | 2025-12-11 | 266187 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2025-12-04 | 2025-12-11 | 273293 |
| TEVA-ONDANSETRON | 4MG | TABLET | Actual shortage | 2025-01-09 | 2025-11-06 | 247360 |
| TEVA-ONDANSETRON | 4MG | TABLET | Actual shortage | 2025-11-06 | 2025-11-06 | 271229 |
| TEVA-ONDANSETRON | 8MG | TABLET | Actual shortage | 2025-11-06 | 2025-11-06 | 271232 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-10-02 | 2019-02-01 | 24103 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-10-02 | 2019-02-01 | 24106 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2019-07-02 | 2019-08-10 | 88213 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2019-12-12 | 2020-03-12 | 101148 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107989 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-03-26 | 2020-07-23 | 109565 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-04-02 | 2020-07-23 | 110661 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2020-07-16 | 2020-09-25 | 120453 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-01-07 | 2021-02-05 | 131078 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |